Filing Details
- Accession Number:
- 0001209191-10-030048
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-24 13:00:00
- Reporting Period:
- 2010-05-20
- Filing Date:
- 2010-05-24
- Accepted Time:
- 2010-05-24 16:53:00
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1012140 | Onyx Pharmaceuticals Inc | ONXX | Biological Products, (No Disgnostic Substances) (2836) | 943154463 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1360376 | Juergen Lasowski | C/O Onyx Pharmaceuticals, Inc. 2100 Powell St., 12Th Floor Emeryville CA 94608 | Svp, Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-05-20 | 592 | $24.06 | 13,869 | No | 4 | S | Direct | |
Common Stock | Disposition | 2010-05-20 | 8 | $24.40 | 13,861 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.